DOCSLIB.ORG

Global Journal of Medical Research

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Global Journal of Medical Research Online ISSN : 2249 - 4618 Print ISSN : 0975 - 5888 Study of Cytological Pattern Development of Animal Models Polymorphism with breast cancer Histopathological and Toxicological effects Volume 12 | Issue 1 | Version 1.0 Global Journal of Medical Research Global Journal of Medical Research Volume 12 Issue 1 (Ver. 1.0) Open Association of Research Society © Global Journal of Medical Global Journals Inc. Research . 2012. (A Delaware USA Incorporation with “Good Standing”; Reg. Number: 0423089) Sponsors: Open Association of Research Society All rights reserved. Open Scientific Standards This is a special issue published in version 1.0 Publisher’s Headquarters office of “Global Journal of Medical Research.” By Global Journals Inc. Global Journals Inc., Headquarters Corporate Office, All articles are open access articles distributed Cambridge Office Center, II Canal Park, Floor No. under “Global Journal of Medical Research” 5th, Cambridge (Massachusetts), Pin: MA 02141 Reading License, which permits restricted use. Entire contents are copyright by of “Global United States Journal of Medical Research” unless USA Toll Free: +001-888-839-7392 otherwise noted on specific articles. USA Toll Free Fax: +001-888-839-7392 No part of this publication may be reproduced Offset Typesetting or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information Open Association of Research Society , Marsh Road, storage and retrieval system, without written permission. Rainham, Essex, London RM13 8EU United Kingdom. The opinions and statements made in this book are those of the authors concerned. Ultraculture has not verified and neither confirms nor denies any of the foregoing and Packaging & Continental Dispatching no warranty or fitness is implied. Engage with the contents herein at your own Global Journals, India risk. The use of this journal, and the terms and Find a correspondence nodal officer near you conditions for our providing information, is governed by our Disclaimer, Terms and Conditions and Privacy Policy given on our To find nodal officer of your country, please ZHEVLWHhttp://globaljournals.us/terms-and-condition/ email us at [email protected] menu-id-1463/ By referring / using / reading / any type of eContacts association / referencing this journal, this signifies and you acknowledge that you have read them and that you accept and will be Press Inquiries: [email protected] bound by the terms thereof. Investor Inquiries: [email protected] Technical Support: [email protected] All information, journals, this journal, activities undertaken, materials, services and Media & Releases: [email protected] our website, terms and conditions, privacy policy, and this journal is subject to change anytime without any prior notice. Pricing (Including by Air Parcel Charges): Incorporation No.: 0423089 License No.: 42125/022010/1186 For Authors: Registration No.: 430374 Import-Export Code: 1109007027 22 USD (B/W) & 50 USD (Color) Employer Identification Number (EIN): USA Tax ID: 98-0673427 Yearly Subscription (Personal & Institutional): 200 USD (B/W) & 250 USD (Color) Editorial Board Members (HON.) John A. Hamilton,"Drew" Jr., Dr. Wenying Feng Ph.D., Professor, Management Professor, Department of Computing & Computer Science and Software Information Systems Engineering Department of Mathematics Director, Information Assurance Trent University, Peterborough, Laboratory ON Canada K9J 7B8 Auburn University Dr. Henry Hexmoor Dr. Thomas Wischgoll IEEE senior member since 2004 Computer Science and Engineering, Ph.D. Computer Science, University at Wright State University, Dayton, Ohio Buffalo B.S., M.S., Ph.D. Department of Computer Science (University of Kaiserslautern) Southern Illinois University at Carbondale Dr. Osman Balci, Professor Dr. Abdurrahman Arslanyilmaz Department of Computer Science Computer Science & Information Systems Virginia Tech, Virginia University Department Ph.D.and M.S.Syracuse University, Youngstown State University Syracuse, New York Ph.D., Texas A&M University M.S. and B.S. Bogazici University, University of Missouri, Columbia Istanbul, Turkey Gazi University, Turkey Yogita Bajpai Dr. Xiaohong He M.Sc. (Computer Science), FICCT Professor of International Business U.S.A.Email: University of Quinnipiac [email protected] BS, Jilin Institute of Technology; MA, MS, PhD,. (University of Texas-Dallas) Dr. T. David A. Forbes Burcin Becerik-Gerber Associate Professor and Range University of Southern California Nutritionist Ph.D. in Civil Engineering Ph.D. Edinburgh University - Animal DDes from Harvard University Nutrition M.S. from University of California, Berkeley M.S. Aberdeen University - Animal & Istanbul University Nutrition B.A. University of Dublin- Zoology Dr. Bart Lambrecht Dr. Söhnke M. Bartram Director of Research in Accounting and Department of Accounting and FinanceProfessor of Finance FinanceLancaster University Management Lancaster University Management School SchoolPh.D. (WHU Koblenz) BA (Antwerp); MPhil, MA, PhD MBA/BBA (University of Saarbrücken) (Cambridge) Dr. Miguel Angel Ariño Dr. Carlos García Pont Professor of Decision Sciences Associate Professor of Marketing IESE Business School IESE Business School, University of Barcelona, Spain (Universidad de Navarra) Navarra CEIBS (China Europe International Business Doctor of Philosophy (Management), School). Massachusetts Institute of Technology Beijing, Shanghai and Shenzhen (MIT) Ph.D. in Mathematics Master in Business Administration, IESE, University of Barcelona University of Navarra BA in Mathematics (Licenciatura) Degree in Industrial Engineering, University of Barcelona Universitat Politècnica de Catalunya Philip G. Moscoso Dr. Fotini Labropulu Technology and Operations Management Mathematics - Luther College IESE Business School, University of Navarra University of ReginaPh.D., M.Sc. in Ph.D in Industrial Engineering and Mathematics Management, ETH Zurich B.A. (Honors) in Mathematics M.Sc. in Chemical Engineering, ETH Zurich University of Windso Dr. Sanjay Dixit, M.D. Dr. Lynn Lim Director, EP Laboratories, Philadelphia VA Reader in Business and Marketing Medical Center Roehampton University, London Cardiovascular Medicine - Cardiac BCom, PGDip, MBA (Distinction), PhD, Arrhythmia FHEA Univ of Penn School of Medicine Dr. Mihaly Mezei Dr. Han-Xiang Deng ASSOCIATE PROFESSOR MD., Ph.D Department of Structural and Chemical Associate Professor and Research Biology, Mount Sinai School of Medical Department Division of Neuromuscular Center Medicine Ph.D., Etvs Lornd University Davee Department of Neurology and Clinical Postdoctoral Training, NeuroscienceNorthwestern University New York University Feinberg School of Medicine Dr. Pina C. Sanelli Dr. Michael R. Rudnick Associate Professor of Public Health M.D., FACP Weill Cornell Medical College Associate Professor of Medicine Associate Attending Radiologist Chief, Renal Electrolyte and NewYork-Presbyterian Hospital Hypertension Division (PMC) MRI, MRA, CT, and CTA Penn Medicine, University of Neuroradiology and Diagnostic Pennsylvania Radiology Presbyterian Medical Center, M.D., State University of New York at Philadelphia Buffalo,School of Medicine and Nephrology and Internal Medicine Biomedical Sciences Certified by the American Board of Internal Medicine Dr. Roberto Sanchez Dr. Bassey Benjamin Esu Associate Professor B.Sc. Marketing; MBA Marketing; Ph.D Department of Structural and Chemical Marketing Biology Lecturer, Department of Marketing, Mount Sinai School of Medicine University of Calabar Ph.D., The Rockefeller University Tourism Consultant, Cross River State Tourism Development Department Co-ordinator , Sustainable Tourism Initiative, Calabar, Nigeria Dr. Wen-Yih Sun Dr. Aziz M. Barbar, Ph.D. Professor of Earth and Atmospheric IEEE Senior Member SciencesPurdue University Director Chairperson, Department of Computer National Center for Typhoon and Science Flooding Research, Taiwan AUST - American University of Science & University Chair Professor Technology Department of Atmospheric Sciences, Alfred Naccash Avenue – Ashrafieh National Central University, Chung-Li, TaiwanUniversity Chair Professor Institute of Environmental Engineering, National Chiao Tung University, Hsin- chu, Taiwan.Ph.D., MS The University of Chicago, Geophysical Sciences BS National Taiwan University, Atmospheric Sciences Associate Professor of Radiology President Editor (HON.) Dr. George Perry, (Neuroscientist) Dean and Professor, College of Sciences Denham Harman Research Award (American Aging Association) ISI Highly Cited Researcher, Iberoamerican Molecular Biology Organization AAAS Fellow, Correspondent Member of Spanish Royal Academy of Sciences University of Texas at San Antonio Postdoctoral Fellow (Department of Cell Biology) Baylor College of Medicine Houston, Texas, United States Chief Author (HON.) Dr. R.K. Dixit M.Sc., Ph.D., FICCT Chief Author, India Email: [email protected] Dean & Editor-in-Chief (HON.) Vivek Dubey(HON.) Er. Suyog Dixit MS (Industrial Engineering), (M. Tech), BE (HONS. in CSE), FICCT MS (Mechanical Engineering) SAP Certified Consultant CEO at IOSRD, GAOR & OSS University of Wisconsin, FICCT Technical Dean, Global Journals Inc. (US) Editor-in-Chief, USA Website: www.suyogdixit.com [email protected] Email:[email protected] Sangita Dixit Pritesh Rajvaidya M.Sc., FICCT (MS) Computer Science Department Dean & Chancellor (Asia Pacific) California State University [email protected]
Load more

Recommended publications
  • IN SILICO ANALYSIS of FUNCTIONAL Snps of ALOX12 GENE and IDENTIFICATION of PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS
    Tulasidharan Suja Saranya et al. Int. Res. J. Pharm. 2014, 5 (6) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Research Article IN SILICO ANALYSIS OF FUNCTIONAL SNPs OF ALOX12 GENE AND IDENTIFICATION OF PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS LIPOXYGENASE INHIBITORS Tulasidharan Suja Saranya, K.S. Silvipriya, Manakadan Asha Asokan* Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Viswa Vidyapeetham University, AIMS Health Sciences Campus, Kochi, Kerala, India *Corresponding Author Email: [email protected] Article Received on: 20/04/14 Revised on: 08/05/14 Approved for publication: 22/06/14 DOI: 10.7897/2230-8407.0506103 ABSTRACT Cancer is a disease affecting any part of the body and in comparison with normal cells there is an elevated level of lipoxygenase enzyme in different cancer cells. Thus generation of lipoxygenase enzyme inhibitors have suggested being valuable. Individual variation was identified by the functional effects of Single Nucleotide Polymorphisms (SNPs). 696 SNPs were identified from the ALOX12 gene, out of which 73 were in the coding non-synonymous region, from which 8 were found to be damaging. In silico analysis was performed to determine naturally occurring flavonoids such as isoflavones having the basic 3- phenylchromen-4-one skeleton for the pharmacological activity, like Genistein, Diadzein, Irilone, Orobol and Pseudobaptigenin. O-methylated isoflavones such as Biochanin, Calycosin, Formononetin, Glycitein, Irigenin, 5-O-Methylgenistein, Pratensein, Prunetin, ψ-Tectorigenin, Retusin and Tectorigenine were also used for the study. Other natural products like Aesculetin, a coumarin derivative; flavones such as ajoene and baicalein were also used for the comparative study of these natural compounds along with acteoside and nordihydroguaiaretic acid (antioxidants) and active inhibitors like Diethylcarbamazine, Zileuton and Azelastine as standard for the computational analysis.
    [Show full text]
  • Download Download
    Volume 3, Issue1, January 2012 Available Online at www.ijppronline.in International Journal Of Pharma Professional’s Research Review Article DALBERGIA SISSOO: AN OVERVIEW ISSN NO:0976-6723 Shivani saini*, Dr. Sunil sharma Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India, 125001 Abstract The present review is, therefore, an effort to give a detailed survey of the literature on its pharamacognosy, phytochemistry, traditional uses and pharmacological studies of the plant Dalbergia sissoo. Dalbergia sissoo is an important timber species around the world. Besides this, it has been utilized as medicines for thousands of years and now there is a growing demand for plant based medicines, health products, pharmaceuticals and cosmetics. Dalbergia sissoo is a widely growing plant which is used traditionally as anti-inflammatory, antipyretic, analgesic, anti-oxidant, anti-diabetic and antimicrobial agent. Several phytoconstituents have been isolated and identified from different parts of the plant belonging tothe category of alkaloids, glycosides, flavanols, tannins, saponins, sterols and terpenoids. A review of plant description, phytochemical constituents present and their pharmacological activities are given in the present article. Keywords: - Dalbergia sissoo, phytochemical constituents, pharmacological activities. Introduction medicine.[7] To be accepted as viable alternative to Medicinal plants have been the part and parcel of modern medicine, the same vigorous method of human society to combat diseases since the dawn of scientific and clinical validation must be applied to human civilization. The earliest description of prove the safety and effectiveness of a therapeutic curative properties of medicinal plants were product.[ 8-9] described in the Rigveda (2500-1800 BC), Charak The genus, Dalbergia, consists of 300 species and Samhita and Sushruta Samhita.
    [Show full text]
  • Ep 3138585 A1
    (19) TZZ¥_¥_T (11) EP 3 138 585 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.03.2017 Bulletin 2017/10 A61L 27/20 (2006.01) A61L 27/54 (2006.01) A61L 27/52 (2006.01) (21) Application number: 16191450.2 (22) Date of filing: 13.01.2011 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • Gousse, Cecile GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 74230 Dingy Saint Clair (FR) PL PT RO RS SE SI SK SM TR • Lebreton, Pierre Designated Extension States: 74000 Annecy (FR) BA ME •Prost,Nicloas 69440 Mornant (FR) (30) Priority: 13.01.2010 US 687048 26.02.2010 US 714377 (74) Representative: Hoffmann Eitle 30.11.2010 US 956542 Patent- und Rechtsanwälte PartmbB Arabellastraße 30 (62) Document number(s) of the earlier application(s) in 81925 München (DE) accordance with Art. 76 EPC: 15178823.9 / 2 959 923 Remarks: 11709184.3 / 2 523 701 This application was filed on 29-09-2016 as a divisional application to the application mentioned (71) Applicant: Allergan Industrie, SAS under INID code 62. 74370 Pringy (FR) (54) STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES (57) The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions. EP 3 138 585 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 138 585 A1 Description CROSS REFERENCE 5 [0001] This patent application is a continuation-in-part of U.S.
    [Show full text]
  • Bioactive Fractions and Compounds from Dalbergia
    (19) TZZ ZZ_T (11) EP 2 705 047 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07H 17/07 (2006.01) A61K 31/7048 (2006.01) 05.08.2015 Bulletin 2015/32 C07D 311/36 (2006.01) A61K 31/352 (2006.01) A61P 19/10 (2006.01) (21) Application number: 12729239.9 (86) International application number: (22) Date of filing: 25.04.2012 PCT/IN2012/000301 (87) International publication number: WO 2012/147102 (01.11.2012 Gazette 2012/44) (54) BIOACTIVE FRACTIONS AND COMPOUNDS FROM DALBERGIA SISSOO FOR THE PREVENTION OR TREATMENT OF OSTEO-HEALTH RELATED DISORDERS BIOAKTIVE FRAKTIONEN UND VERBINDUNGEN AUS DALBERGIA SISSOO ZUR VORBEUGUNG ODER BEHANDLUNG KNOCHENZUSTANDSBEDINGTER ERKRANKUNGEN FRACTIONS ET COMPOSÉS BIOACTIFS ISSUS DE DALBERGIA SISSOO POUR PRÉVENIR OU TRAITER LES TROUBLES D’ORIGINE OSTÉOPATHIQUE (84) Designated Contracting States: • WAHAJUDDIN AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Lucknow 226001 (IN) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • JAIN, Girish, Kumar PL PT RO RS SE SI SK SM TR Lucknow 226001 (IN) • CHATTOPADHYAY, Naibedya (30) Priority: 25.04.2011 IN DE12062011 Lucknow 226001 (IN) (43) Date of publication of application: (74) Representative: Jakobsson, Jeanette Helene 12.03.2014 Bulletin 2014/11 Awapatent AB P.O. Box 5117 (73) Proprietor: Council of Scientific & Industrial 200 71 Malmö (SE) Research New Delhi 110 001 (IN) (56) References cited: WO-A2-00/62765 WO-A2-2007/042010 (72) Inventors: FR-A1- 2 483 228 • MAURYA, Rakesh Lucknow 226001 (IN) • PREETY DIXIT ET AL: "Constituents of Dalbergia • DIXIT, Preety sissoo Roxb.
    [Show full text]
  • Natural Products As Chemopreventive Agents by Potential Inhibition of the Kinase Domain in Erbb Receptors
    Supplementary Materials: Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErBb Receptors Maria Olivero-Acosta, Wilson Maldonado-Rojas and Jesus Olivero-Verbel Table S1. Protein characterization of human HER Receptor structures downloaded from PDB database. Recept PDB resid Resolut Name Chain Ligand Method or Type Code ues ion Epidermal 1,2,3,4-tetrahydrogen X-ray HER 1 2ITW growth factor A 327 2.88 staurosporine diffraction receptor 2-{2-[4-({5-chloro-6-[3-(trifl Receptor uoromethyl)phenoxy]pyri tyrosine-prot X-ray HER 2 3PP0 A, B 338 din-3-yl}amino)-5h-pyrrolo 2.25 ein kinase diffraction [3,2-d]pyrimidin-5-yl]etho erbb-2 xy}ethanol Receptor tyrosine-prot Phosphoaminophosphonic X-ray HER 3 3LMG A, B 344 2.8 ein kinase acid-adenylate ester diffraction erbb-3 Receptor N-{3-chloro-4-[(3-fluoroben tyrosine-prot zyl)oxy]phenyl}-6-ethylthi X-ray HER 4 2R4B A, B 321 2.4 ein kinase eno[3,2-d]pyrimidin-4-ami diffraction erbb-4 ne Table S2. Results of Multiple Alignment of Sequence Identity (%ID) Performed by SYBYL X-2.0 for Four HER Receptors. Human Her PDB CODE 2ITW 2R4B 3LMG 3PP0 2ITW (HER1) 100.0 80.3 65.9 82.7 2R4B (HER4) 80.3 100 71.7 80.9 3LMG (HER3) 65.9 71.7 100 67.4 3PP0 (HER2) 82.7 80.9 67.4 100 Table S3. Multiple alignment of spatial coordinates for HER receptor pairs (by RMSD) using SYBYL X-2.0. Human Her PDB CODE 2ITW 2R4B 3LMG 3PP0 2ITW (HER1) 0 4.378 4.162 5.682 2R4B (HER4) 4.378 0 2.958 3.31 3LMG (HER3) 4.162 2.958 0 3.656 3PP0 (HER2) 5.682 3.31 3.656 0 Figure S1.
    [Show full text]
  • 中国科技论文在线 Pro-Apoptotic Effects of Tectorigenin on Human
    中国科技论文在线 http://www.paper.edu.cn Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells# DING Hui, SHI Dahua, LI Erguang, WANG Yurong, JIANG Chunping, 5 WU Junhua** (Jiangsu Key Laboratory of Molecular Medicine, State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, NanJing 210093) Abstract: Tectorigenin, a main isoflavone in the Iris tectorum rhizome which was used traditionally for treating liver-related diseases, was shown to inhibit the growth of human hepatoma HepG2 cells, 10 and to induce the cell apoptosis. In the apoptotic process, the intracellular ROS and Ca2+ elevation acted as an early event followed by depolarization of mitochondrial membrane potential (MMP). And then cytochrome c was released to cytosol. Moreover, the tectorigenin treatment co-enhanced the caspase-3, -8 and -9 proteolytic activities. In conclusion, tectorigenin significantly inhibited the proliferation and induced apoptosis in human hepatocellular carcinoma HepG2 cells mainly via 15 mitochondrial-mediated pathway. And the death receptor-dependent pathway might play a certain role in the apoptotic process. These observations indicated that tectorigenin is the active principle of Iris tectorum rhizome applied in the folk medicine for alleviating liver disorders, and that the isoflavone is a promising candidate for hepatocellular carcinoma chemotherapeutic and chemopreventive agent. Keywords: Tectorigenin; Anti-proliferation; Apoptosis; Mitochondrial; HepG2 20 0 Introduction Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide, with 600 000 deaths per year[1]. It often develops in patients with chronic liver diseases associated with hepatitis B (HBV) or hepatitis C (HCV) virus infections[1]. Although 25 surgical techniques have been improved and several non-surgical treatment modalities have been developed, there is no effective therapy for significant improvement of extremely poor prognosis of HCC patients[2].
    [Show full text]
  • ACHROM-2021.00936 Proof 1..7
    Pharmacokinetics of tectorigenin, tectoridi, irigenin, and iridin in mouse blood after intravenous administration by UPLC-MS/MS Acta Chromatographica JIANBO LI1, YUQI YAO2, MINYUE ZHOU2, ZHENG YU2, YINAN JIN2 and XIANQIN WANG2p DOI: 1 fi 10.1556/1326.2021.00936 The Second Af liated Hospital Zhejiang University School of Medicine Yuhang Campus, © 2021 The Author(s) Hangzhou, China 2 Analytical and Testing Centre, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China Received: May 25, 2021 • Accepted: July 12, 2021 ORIGINAL RESEARCH PAPER ABSTRACT Tectorigenin, tectoridin, irigenin, and iridin are the four most predominant compounds present in She Gan. She Gan has been used in traditional Chinese medicine because of its anti-inflammatory, hep- atoprotective, anti-tumor, antioxidant, phytoestrogen-like properties. In this paper, a UPLC-MS/MS method was developed to measure the pharmacokinetics of tectorigenin, tectoridin, irigenin, iridin after intravenous administration in mice. A UPLC BEH C18 (50 mm 3 2.1 mm, 1.7 mm particle size) chro- matographic column was utilized for separation of the four target analytes and internal standard (IS), and the analysis of blood plasma samples; the mobile phase consisted of an acetonitrile-water (w/0.1% formic acid) gradient elution. Electron spray ionization (ESI) positive-ion mode and multiple reaction monitoring (MRM) mode was used for quantitative analysis of the analytes and internal standard. The four compounds were administered intravenously (sublingual) at doses of 5 mg/kg. After blood sam- pling, samples were processed and then analyzed by UPLC-MS/MS. The linearity of the method was robust over the concentration range of 2–5,000 ng/mL.
    [Show full text]
  • Iridin Induces G2/M Phase Cell Cycle Arrest and Extrinsic Apoptotic Cell Death Through PI3K/AKT Signaling Pathway in AGS Gastric Cancer Cells
    molecules Article Iridin Induces G2/M Phase Cell Cycle Arrest and Extrinsic Apoptotic Cell Death through PI3K/AKT Signaling Pathway in AGS Gastric Cancer Cells Pritam-Bhagwan Bhosale 1 , Preethi Vetrivel 1, Sang-Eun Ha 1, Hun-Hwan Kim 1, Jeong-Doo Heo 2, Chung-Kil Won 1, Seong-Min Kim 1,* and Gon-Sup Kim 1,* 1 Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Korea; [email protected] (P.-B.B.); [email protected] (P.V.); [email protected] (S.-E.H.); [email protected] (H.-H.K.); [email protected] (C.-K.W.) 2 Biological Resources Research Group, Bioenvironmental Science & Toxicology Division, Korea Institute of Toxicology (KIT), 17 Jeigok-gil, Jinju 52834, Korea; [email protected] * Correspondence: [email protected] (S.-M.K.); [email protected] (G.-S.K.); Tel.: +82-10-3834-5823 (G.-S.K.) Abstract: Iridin is a natural flavonoid found in Belamcanda chinensis documented for its broad spectrum of biological activities like antioxidant, antitumor, and antiproliferative effects. In the present study, we have investigated the antitumor potential of iridin in AGS gastric cancer cells. Iridin treatment decreases AGS cell growth and promotes G2/M phase cell cycle arrest by attenuating the expression of Cdc25C, CDK1, and Cyclin B1 proteins. Iridin-treatment also triggered apoptotic cell death in AGS cells, which was verified by cleaved Caspase-3 (Cl- Caspase-3) and poly ADP-ribose Citation: Bhosale, P.-B.; Vetrivel, P.; polymerase (PARP) protein expression. Further apoptotic cell death was confirmed by increased Ha, S.-E.; Kim, H.-H.; Heo, J.-D.; apoptotic cell death fraction shown in allophycocyanin (APC)/Annexin V and propidium iodide Won, C.-K.; Kim, S.-M.; Kim, G.-S.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano Et Al
    US 20090269772A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano et al. (43) Pub. Date: Oct. 29, 2009 (54) SYSTEMS AND METHODS FOR Publication Classification IDENTIFYING COMBINATIONS OF (51) Int. Cl. COMPOUNDS OF THERAPEUTIC INTEREST CI2O I/68 (2006.01) CI2O 1/02 (2006.01) (76) Inventors: Andrea Califano, New York, NY G06N 5/02 (2006.01) (US); Riccardo Dalla-Favera, New (52) U.S. Cl. ........... 435/6: 435/29: 706/54; 707/E17.014 York, NY (US); Owen A. (57) ABSTRACT O'Connor, New York, NY (US) Systems, methods, and apparatus for searching for a combi nation of compounds of therapeutic interest are provided. Correspondence Address: Cell-based assays are performed, each cell-based assay JONES DAY exposing a different sample of cells to a different compound 222 EAST 41ST ST in a plurality of compounds. From the cell-based assays, a NEW YORK, NY 10017 (US) Subset of the tested compounds is selected. For each respec tive compound in the Subset, a molecular abundance profile from cells exposed to the respective compound is measured. (21) Appl. No.: 12/432,579 Targets of transcription factors and post-translational modu lators of transcription factor activity are inferred from the (22) Filed: Apr. 29, 2009 molecular abundance profile data using information theoretic measures. This data is used to construct an interaction net Related U.S. Application Data work. Variances in edges in the interaction network are used to determine the drug activity profile of compounds in the (60) Provisional application No. 61/048.875, filed on Apr.
    [Show full text]
  • Anti-Helicobacter Pylori Compounds from Maackia Amurensis
    Natural Product Sciences 21(1) : 49-53 (2015) Anti-Helicobacter pylori Compounds from Maackia amurensis Woo Sung Park1, Ji-Yeong Bae1, Hye Jin Kim1, Min Gab Kim1, Woo-Kon Lee2, Hyung-Lyun Kang2, Seung-Chul Baik2, Kyung Mook Lim3, Mi Kyeong Lee4, and Mi-Jeong Ahn1,* 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 660-701, Korea 2Department of Microbiology, School of Medicine and Research Institute of Life Sciences, Gyeongsang National University, Jinju 660-751, Korea 3Cho-A Pharmaceutical Company, Seoul 150-902, Korea 4College of Pharmacy, Chungbuk National University, Cheongju 361-763, Korea Abstract − Eight isoflavonoid compounds were isolated from the EtOAc fraction of Maackia amurensis which had shown the highest anti-Helicobacter pylori activity among the fractions, using medium pressure liquid chromatography and recrystallization. Based on the spectroscopic data including 1H-NMR, 13C-NMR, HMBC and MS data, the chemical structures of the isolates were determined to be (−)-medicarpin (1), afromosin (2), formononetin (3), tectorigenin (4), prunetin (5), wistin (6), tectoridin (7) and ononin (8). Anti-H. pylori activity of each compound was evaluated with broth dilution assay. As a result, (−)-medicarpin (1), tectorigenin (4) and wistin (6) showed anti-H. pylori activity. (−)-Medicarpin (1) exhibited the most potent growth inhibitory activity against H. pylori with the minimal inhibitory concentration (MIC)90 of 25 µM, and tectorigenin (4) with MIC90 of 100 µM ranked the second. This is the first study to show the anti-H. pylori activity of M. amurensis, and it is suggested that the stem bark of M. amurensis or the EtOAc fraction or the isolated compounds can be a new natural source for the treatment of H.
    [Show full text]
  • Evaluation of the Estrogenic Activity of Pueraria (Kudzu) Flower Extract and Its Major Isoflavones Using ER-Binding and Uterotrophic Bioassays
    Pharmacology & Pharmacy, 2013, 4, 255-260 255 http://dx.doi.org/10.4236/pp.2013.42036 Published Online April 2013 (http://www.scirp.org/journal/pp) Evaluation of the Estrogenic Activity of Pueraria (Kudzu) Flower Extract and Its Major Isoflavones Using ER-Binding and Uterotrophic Bioassays Tomoyasu Kamiya1*, Akira Takano1, Yayoi Kido1, Yuki Matsuzuka1, Mayu Sameshima-Kamiya1, Masahito Tsubata1, Motoya Ikeguchi1, Kinya Takagaki1, Junei Kinjo2 1Research and Development Division, Toyoshinyaku Co. Ltd., Tosu-shi, Japan; 2Faculty of Pharmaceutical Sciences, Fukuoka Uni- versity, Fukuoka, Japan. Email: *[email protected] Received January 20th, 2013; revised March 5th, 2013; accepted April 14th, 2013 Copyright © 2013 Tomoyasu Kamiya et al. This is an open access article distributed under the Creative Commons Attribution Li- cense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Pueraria flower extract (PFE) is a hot water extract of the Kudzu flower (Pueraria thomsonii). Tea made from dried Kudzu flower is widely used in China, and PFE is utilized as a nutritional supplement in Japan. PFE contains unique isoflavones such as 6-hydroxygenistein 6,7-di-O-glucoside (6HGDG), tectorigenin 7-O-xylosylglucoside (TGXG), and tectoridin. 6HGDG is known to be metabolized into 6-hydroxygenistein, and TGXG and tectoridin are known to be metabolized into tectorigenin in the digestive tract. Isoflavones typically mimic the effects β-estradiol has on estrogen receptors (ERs) and may influence the female genital system in the case of excessive intake. As a result, the upper limit of safe daily consumption of soy isoflavones has been enforced in Japan.
    [Show full text]
  • Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation Of
    Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation of the Coronary Artery Through the Calcium Channel and cGMP-dependent Pathway Thomas Migkos, Jana Pourová, Marie Vopršalová, Cyril Auger, Valérie Schini-Kerth, Přemysl Mladěnka To cite this version: Thomas Migkos, Jana Pourová, Marie Vopršalová, Cyril Auger, Valérie Schini-Kerth, et al.. Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation of the Coronary Artery Through the Calcium Channel and cGMP-dependent Pathway. Planta Medica, Georg Thieme Verlag, 2020, 86 (10), pp.708 - 716. 10.1055/a-1158-9422. hal-03033813 HAL Id: hal-03033813 https://hal-cnrs.archives-ouvertes.fr/hal-03033813 Submitted on 1 Dec 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Published online: 2020-05-14 Original Papers Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation of the Coronary Artery Through the Calcium Channel and cGMP-dependent Pathway Authors Thomas Migkos1, Jana Pourová 1,MarieVopršalová 1, Cyril Auger 2, Valérie Schini-Kerth 2,Přemysl Mladěnka 1 Affiliations Supporting information available online at 1 Department of Pharmacology and Toxicology, Faculty of http://www.thieme-connect.de/products Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic ABSTRACT 2 INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), The dietary intake of flavonoids seems to be inversely related FMTS, Université de Strasbourg, Faculté de Pharmacie, to cardiovascular mortality.
    [Show full text]